These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33203640)

  • 1. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
    Lai AG; Pasea L; Banerjee A; Hall G; Denaxas S; Chang WH; Katsoulis M; Williams B; Pillay D; Noursadeghi M; Linch D; Hughes D; Forster MD; Turnbull C; Fitzpatrick NK; Boyd K; Foster GR; Enver T; Nafilyan V; Humberstone B; Neal RD; Cooper M; Jones M; Pritchard-Jones K; Sullivan R; Davie C; Lawler M; Hemingway H
    BMJ Open; 2020 Nov; 10(11):e043828. PubMed ID: 33203640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
    Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic.
    Banerjee A; Chen S; Pasea L; Lai AG; Katsoulis M; Denaxas S; Nafilyan V; Williams B; Wong WK; Bakhai A; Khunti K; Pillay D; Noursadeghi M; Wu H; Pareek N; Bromage D; McDonagh TA; Byrne J; Teo JTH; Shah AM; Humberstone B; Tang LV; Shah ASV; Rubboli A; Guo Y; Hu Y; Sudlow CLM; Lip GYH; Hemingway H
    Eur J Prev Cardiol; 2021 Dec; 28(14):1599-1609. PubMed ID: 33611594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance.
    Odone A; Delmonte D; Gaetti G; Signorelli C
    Public Health; 2021 Jan; 190():108-115. PubMed ID: 33412438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020.
    Wu J; Mafham M; Mamas MA; Rashid M; Kontopantelis E; Deanfield JE; de Belder MA; Gale CP
    Mayo Clin Proc; 2021 Apr; 96(4):952-963. PubMed ID: 33714592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.
    Kontopantelis E; Mamas MA; Deanfield J; Asaria M; Doran T
    J Epidemiol Community Health; 2021 Mar; 75(3):213-223. PubMed ID: 33060194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing patterns of mortality during the COVID-19 pandemic: Population-based modelling to understand palliative care implications.
    Bone AE; Finucane AM; Leniz J; Higginson IJ; Sleeman KE
    Palliat Med; 2020 Oct; 34(9):1193-1201. PubMed ID: 32706299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data.
    Carey IM; Cook DG; Harris T; DeWilde S; Chaudhry UAR; Strachan DP
    PLoS One; 2021; 16(12):e0260381. PubMed ID: 34882700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic.
    Blangiardo M; Cameletti M; Pirani M; Corsetti G; Battaglini M; Baio G
    PLoS One; 2020; 15(10):e0240286. PubMed ID: 33035253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    Strongman H; Carreira H; De Stavola BL; Bhaskaran K; Leon DA
    PLoS Med; 2022 Jan; 19(1):e1003870. PubMed ID: 34990450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.
    Lewnard JA; Mahmud A; Narayan T; Wahl B; Selvavinayagam TS; Mohan B C; Laxminarayan R
    Lancet Infect Dis; 2022 Apr; 22(4):463-472. PubMed ID: 34953536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022.
    Lee WE; Woo Park S; Weinberger DM; Olson D; Simonsen L; Grenfell BT; Viboud C
    Elife; 2023 Feb; 12():. PubMed ID: 36811598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking mortality in near to real time provides essential information about the impact of the COVID-19 pandemic in South Africa in 2020.
    Bradshaw D; Dorrington RE; Laubscher R; Moultrie TA; Groenewald P
    S Afr Med J; 2021 May; 111(8):732-740. PubMed ID: 35227353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of lockdown? A population-based electronic health record study.
    Katsoulis M; Pasea L; Lai AG; Dobson RJB; Denaxas S; Hemingway H; Banerjee A
    Public Health; 2021 Feb; 191():41-47. PubMed ID: 33497994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.
    Cevallos-Valdiviezo H; Vergara-Montesdeoca A; Zambrano-Zambrano G
    Int J Infect Dis; 2021 Mar; 104():297-299. PubMed ID: 33352328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention in England in the Pre-COVID and COVID Eras.
    Mohamed MO; Kinnaird T; Curzen N; Ludman P; Wu J; Rashid M; Shoaib A; de Belder M; Deanfield J; Gale CP; Mamas MA
    J Invasive Cardiol; 2021 Mar; 33(3):E206-E219. PubMed ID: 33348315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the burden of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: a population-level analysis.
    Aburto JM; Kashyap R; Schöley J; Angus C; Ermisch J; Mills MC; Dowd JB
    J Epidemiol Community Health; 2021 Aug; 75(8):735-740. PubMed ID: 33468602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the impact of lockdown-easing measures on cumulative COVID-19 cases and deaths in England.
    Ziauddeen H; Subramaniam N; Gurdasani D
    BMJ Open; 2021 Sep; 11(9):e042483. PubMed ID: 34497074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.